Kingworld Medicines Group Ltd. (HK:1110) has released an update.
Kingworld Medicines Group Ltd. reported a decrease in revenue and profit for the first half of 2024 compared to the same period in 2023, with revenue down by 4.9% and profits for the period falling by 4.4%. The company’s gross profit margin also saw a reduction of 1.9 percentage points. Despite the declines, the company managed a valuation gain on investment properties and shared profits from a joint venture and an associate.
For further insights into HK:1110 stock, check out TipRanks’ Stock Analysis page.
